Ginkgo Bioworks Holdings (DNA) Shares Fall Despite Market Gains

Ginkgo Bioworks Holdings, Inc. (DNA) stock fell 2.53% to $10.79, lagging the S&P 500's 0.28% gain. The company's stock has risen 13.19% in the past month, outperforming the Medical sector's 0.24% gain and the S&P 500's 4.37% gain. Analysts expect a 55% increase in Q4 EPS and a 20.72% decline in revenue compared to the previous year. The Zacks Rank is #2 (Buy).